First Trust Advisors LP Sells 48,610 Shares of Teladoc Health, Inc. (NYSE:TDOC)

First Trust Advisors LP reduced its stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 79.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 12,210 shares of the health services provider's stock after selling 48,610 shares during the period. First Trust Advisors LP's holdings in Teladoc Health were worth $111,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in TDOC. Whipplewood Advisors LLC acquired a new stake in shares of Teladoc Health in the 4th quarter worth approximately $29,000. Lindbrook Capital LLC boosted its holdings in Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock worth $33,000 after buying an additional 1,612 shares in the last quarter. Sterling Capital Management LLC boosted its holdings in Teladoc Health by 776.7% during the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock worth $42,000 after buying an additional 4,101 shares in the last quarter. Pilgrim Partners Asia Pte Ltd bought a new stake in Teladoc Health during the fourth quarter worth approximately $60,000. Finally, Generali Investments Management Co LLC bought a new stake in Teladoc Health during the fourth quarter worth approximately $64,000. 76.82% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares of the company's stock, valued at $541,473.36. This represents a 14.62% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.58% of the company's stock.

Analysts Set New Price Targets

TDOC has been the subject of a number of research reports. Oppenheimer reduced their target price on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a report on Friday, January 24th. Bank of America reduced their target price on shares of Teladoc Health from $9.50 to $8.00 and set a "neutral" rating for the company in a report on Friday, April 11th. Wells Fargo & Company reduced their price target on shares of Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research report on Thursday, May 8th. Citigroup reduced their price target on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research report on Friday, April 25th. Finally, Evercore ISI reduced their price target on shares of Teladoc Health from $8.00 to $7.00 and set an "in-line" rating for the company in a research report on Thursday, May 1st. Twelve research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, Teladoc Health presently has an average rating of "Hold" and a consensus price target of $9.71.

Teladoc Health Stock Up 1.6%

Shares of TDOC traded up $0.12 during mid-day trading on Friday, hitting $7.37. 1,237,329 shares of the company's stock were exchanged, compared to its average volume of 6,219,054. The firm has a fifty day moving average of $7.61 and a two-hundred day moving average of $9.37. Teladoc Health, Inc. has a twelve month low of $6.35 and a twelve month high of $15.21. The stock has a market cap of $1.29 billion, a price-to-earnings ratio of -1.28 and a beta of 1.82. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The business had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, sell-side analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.